These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 31921194)
1. Wanted Dead or Alive: A Correlate of Protection Against Dengue Virus. Gil L; Martín A; Lazo L Front Immunol; 2019; 10():2946. PubMed ID: 31921194 [No Abstract] [Full Text] [Related]
3. The Interplay of Dengue Virus Morphological Diversity and Human Antibodies. Lok SM Trends Microbiol; 2016 Apr; 24(4):284-293. PubMed ID: 26747581 [TBL] [Abstract][Full Text] [Related]
7. Vaccination models and optimal control strategies to dengue. Rodrigues HS; Monteiro MT; Torres DF Math Biosci; 2014 Jan; 247():1-12. PubMed ID: 24513243 [TBL] [Abstract][Full Text] [Related]
8. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens. Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114 [TBL] [Abstract][Full Text] [Related]
9. Is Dengvaxia a useful vaccine for dengue endemic areas? Gubler DJ; Halstead SB BMJ; 2019 Oct; 367():l5710. PubMed ID: 31582375 [No Abstract] [Full Text] [Related]
10. Immune response to dengue virus and prospects for a vaccine. Murphy BR; Whitehead SS Annu Rev Immunol; 2011; 29():587-619. PubMed ID: 21219187 [TBL] [Abstract][Full Text] [Related]
11. Unique challenges faced by the clinical evaluation of dengue vaccines. Edelman R Expert Rev Vaccines; 2011 Feb; 10(2):133-6. PubMed ID: 21332260 [No Abstract] [Full Text] [Related]
12. Evaluation of interferences between dengue vaccine serotypes in a monkey model. Guy B; Barban V; Mantel N; Aguirre M; Gulia S; Pontvianne J; Jourdier TM; Ramirez L; Gregoire V; Charnay C; Burdin N; Dumas R; Lang J Am J Trop Med Hyg; 2009 Feb; 80(2):302-11. PubMed ID: 19190230 [TBL] [Abstract][Full Text] [Related]
15. Anti-dengue Vaccines: From Development to Clinical Trials. Pinheiro-Michelsen JR; Souza RDSO; Santana IVR; da Silva PS; Mendez EC; Luiz WB; Amorim JH Front Immunol; 2020; 11():1252. PubMed ID: 32655561 [No Abstract] [Full Text] [Related]
16. Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines. Borges MB; Marchevsky RS; Carvalho Pereira R; da Silva Mendes Y; Almeida Mendes LG; Diniz-Mendes L; Cruz MA; Tahmaoui O; Baudart S; Freire M; Homma A; Schneider-Ohrum K; Vaughn DW; Vanloubbeeck Y; Lorin C; Malice MP; Caride E; Warter L PLoS Pathog; 2019 Apr; 15(4):e1007721. PubMed ID: 31009499 [TBL] [Abstract][Full Text] [Related]
17. Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine. Liang H; Lee M; Jin X Cell Mol Immunol; 2016 Jan; 13(1):36-46. PubMed ID: 26435066 [TBL] [Abstract][Full Text] [Related]
18. Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4. Barban V; Mantel N; De Montfort A; Pagnon A; Pradezynski F; Lang J; Boudet F J Virol; 2018 Jun; 92(12):. PubMed ID: 29593041 [TBL] [Abstract][Full Text] [Related]
19. Dengue vaccine: an update on recombinant subunit strategies. Martin J; Hermida L Acta Virol; 2016 Mar; 60(1):3-14. PubMed ID: 26982462 [TBL] [Abstract][Full Text] [Related]
20. Mosquito control might not bolster imperfect dengue vaccines. Paul R; Sousa C; Sakuntabhai A; Devine G Lancet; 2014 Nov; 384(9956):1747-8. PubMed ID: 25455246 [No Abstract] [Full Text] [Related] [Next] [New Search]